Per Stirling Capital Management, Llc. Leap Therapeutics, Inc. Transaction History

Per Stirling Capital Management, Llc.

  • $721 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.42 - $9.18 $9,030 - $197,388
21,502 New
21,502 $9.68 Million

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $275M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Per Stirling Capital Management, Llc. Portfolio

Follow Per Stirling Capital Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Per Stirling Capital Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Per Stirling Capital Management, Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email